Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19.

Saved in:
Bibliographic Details
Title: Infection and infectivity: Utility of rapid antigen tests for the diagnosis of COVID-19.
Authors: Barreiro, Pablo1 pablo.barreiro@salud.madrid.org, San-Román, Jesús1, Mar Carretero, María del1, Javier Candel, Francisco1
Source: Revista Española de Quimioterapia. 2021 Supplement, Vol. 34, p46-48. 3p.
Subjects: COVID-19 testing, PROTEIN analysis, VIRAL load, POLYMERASE chain reaction, MEDICAL screening
Abstract: Detection of SARS-CoV-2 proteins is commercially available in the form of lateral-flow rapid antigen test for the point-of-care diagnosis of COVID-19. This platform has been validated for symptomatic and asymptomatic individuals, for diagnosis or screening, and as part of single or sequential diagnostic strategies. Although in general less sensitive than amplification techniques, antigen tests may be particularly valid during the first days of symptoms and to detect individuals with greater viral load, thereby with enhanced chances of viral transmission. The simplicity of antigen tests make them very suitable to discard infection in settings with low pretest probability, and to detect infection in case of higher chances of having COVID-19. [ABSTRACT FROM AUTHOR]
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: MedicLatina
Description
Abstract:Detection of SARS-CoV-2 proteins is commercially available in the form of lateral-flow rapid antigen test for the point-of-care diagnosis of COVID-19. This platform has been validated for symptomatic and asymptomatic individuals, for diagnosis or screening, and as part of single or sequential diagnostic strategies. Although in general less sensitive than amplification techniques, antigen tests may be particularly valid during the first days of symptoms and to detect individuals with greater viral load, thereby with enhanced chances of viral transmission. The simplicity of antigen tests make them very suitable to discard infection in settings with low pretest probability, and to detect infection in case of higher chances of having COVID-19. [ABSTRACT FROM AUTHOR]
ISSN:02143429
DOI:10.37201/req/s01.14.2021